Home Covid-19
The lung disease Covid-19, which is caused by the novel coronavirus known as SARS-CoV-2, has the world in its grip. GBN is bringing biobanks and researchers together to gain insights into the disease and develop treatments.
See here for information on handling biosamples as well as further literature.
From swabs to whole blood – these German biobanks are collecting SARS-CoV-2 samples.
02/03/2023
In the European Journal of Human Genetics, a GBN/GBA team of authors presents a workflow for reporting incidental findings.
01/17/2023
The first training since the beginning of the Corona pandemic took place on the topic of "TMA-based tissue preparation for multiplex imaging".
01/11/2023
For technicians interested in on-site training offered by GBN, successful completion of the module is a prerequisite for participation.
germanbiobanknode@charite.de
Tel. +49. 30. 450 536 347
Fax +49. 30. 450 753 69 38
© 2023 All rights reserved.
